Literature DB >> 2357580

Cysteinyl-leukotriene production during limbic seizures triggered by kainic acid.

T Simmet1, B Tippler.   

Abstract

In rats kainic acid-induced seizures were accompanied by time-dependent cerebral cysteinyl-leukotriene (LT) and prostaglandin (PG) F2 alpha formation. Cysteinyl-LT were identified in the rat brain tissue extracts by their immunoreactive properties and their retention times upon reversed phase HPLC profiling. In perfused blood-free brain tissue contents of LTC4-like material were significantly elevated in cortex, hippocampus, midbrain and hypothalamus at 3 h after kainic acid injection. PGF2 alpha tissue contents were significantly elevated in all brain areas studied with very large amounts in the hippocampus and smaller amounts in the cortex. The cyclooxygenase inhibitor indomethacin significantly inhibited formation of PGF2 alpha in whole brain tissue while leaving unaffected the production of cysteinyl-LT. A dose of indomethacin which nearly completely inhibited cyclooxygenase activity as monitored by cerebral PGF2 alpha contents also tended to aggravate behavioral changes and significantly increased the mortality. Phenidone, a lipoxygenase inhibitor, significantly and dose-dependently inhibited formation of cysteinyl-LT but did not significantly affect PGF2 alpha formation. Seizure activity tended to be attenuated by a higher dose of this compound. Dexamethasone which supposedly inhibits phospholipase A2 activity by induction of lipocortins, did not significantly reduce either cysteinyl-LT or PGF2 alpha biosynthesis. Flunarizine, trifluoperazine and diazepines protected a certain percentage of animals from kainic acid-induced seizures. In rats in which seizures occurred in spite of pretreatment with these compounds, the eicosanoid formation was not inhibited but in the case of flunarizine was even found to be somewhat enhanced.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357580     DOI: 10.1016/0006-8993(90)90579-z

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.

Authors:  S Palumbo; C D Toscano; L Parente; R Weigert; F Bosetti
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-05-06       Impact factor: 4.006

2.  5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease.

Authors:  Omidreza Firuzi; Jiamin Zhuo; Cinzia M Chinnici; Thomas Wisniewski; Domenico Praticò
Journal:  FASEB J       Date:  2007-11-12       Impact factor: 5.191

3.  Effect of 3-morpholinosydnonimine (SIN-1) and NG-nitro-L-arginine (NNA) on isolated perfused anaphylactic guinea-pig hearts.

Authors:  K I Thelen; A Dembinska-Kiéc; D Pallapies; T Simmet; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

4.  Montelukast reduces seizures in pentylenetetrazol-kindled mice.

Authors:  J Fleck; F R Temp; J R Marafiga; A C Jesse; L H Milanesi; L M Rambo; C F Mello
Journal:  Braz J Med Biol Res       Date:  2016-02-23       Impact factor: 2.590

Review 5.  Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.

Authors:  Paolo Gelosa; Francesca Colazzo; Elena Tremoli; Luigi Sironi; Laura Castiglioni
Journal:  Mediators Inflamm       Date:  2017-05-10       Impact factor: 4.711

Review 6.  Montelukast: The New Therapeutic Option for the Treatment of Epilepsy.

Authors:  Bekalu Amare Tesfaye; Haftom Gebregergs Hailu; Kaleab Alemayehu Zewdie; Muluken Altaye Ayza; Derbew Fikadu Berhe
Journal:  J Exp Pharmacol       Date:  2021-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.